Otoferlin acts as a Ca2+ sensor for vesicle fusion and vesicle pool replenishment at auditory hair cell ribbon synapses

  1. Nicolas Antoine Michalski  Is a corresponding author
  2. Juan D Goutman
  3. Sarah Marie Auclair
  4. Jacques Boutet de Monvel
  5. Margot Tertrais
  6. Alice Emptoz
  7. Alexandre Parrin
  8. Sylvie Nouaille
  9. Marc Guillon
  10. Martin Sachse
  11. Danica Ciric
  12. Amel Bahloul
  13. Jean-Pierre Hardelin
  14. Roger Bryan Sutton
  15. Paul Avan
  16. Shyam S Krishnakumar
  17. James E Rothman
  18. Didier Dulon
  19. Saaid Safieddine
  20. Christine Petit  Is a corresponding author
  1. Institut Pasteur, France
  2. Universidad de Buenos Aires, Argentina
  3. Yale University School of Medicine, United States
  4. UMRS 1120, Institut National de la Santé et de la Recherche Médicale (INSERM), France
  5. Université Paris Descartes, Sorbonne Paris Cité, France
  6. Texas Tech University Health Sciences Center, United States
  7. Université d'Auvergne, France

Abstract

Hearing relies on rapid, temporally precise, and sustained neurotransmitter release at the ribbon synapses of sensory cells, the inner hair cells (IHCs). This process requires otoferlin, a six C2-domain, Ca2+-binding transmembrane protein of synaptic vesicles. To decipher the role of otoferlin in the synaptic vesicle cycle, we produced knock-in mice (OtofAla515,Ala517/Ala515,Ala517) with lower Ca2+-binding affinity of the C2C domain. The IHC ribbon synapse structure, synaptic Ca2+ currents, and otoferlin distribution were unaffected in these mutant mice, but auditory brainstem response wave-I amplitude was reduced. Lower Ca2+ sensitivity and delay of the fast and sustained components of synaptic exocytosis were revealed by membrane capacitance measurement upon modulations of intracellular Ca2+ concentration, by varying Ca2+ influx through voltage-gated Ca2+-channels or Ca2+ uncaging. Otoferlin thus functions as a Ca2+ sensor, setting the rates of primed vesicle fusion with the presynaptic plasma membrane and synaptic vesicle pool replenishment in the IHC active zone.

Article and author information

Author details

  1. Nicolas Antoine Michalski

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    For correspondence
    nicolas.michalski@pasteur.fr
    Competing interests
    No competing interests declared.
  2. Juan D Goutman

    Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Universidad de Buenos Aires, Buenos Aires, Argentina
    Competing interests
    No competing interests declared.
  3. Sarah Marie Auclair

    Department of Cell Biology, Yale University School of Medicine, New Haven, United States
    Competing interests
    No competing interests declared.
  4. Jacques Boutet de Monvel

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  5. Margot Tertrais

    UMRS 1120, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
    Competing interests
    No competing interests declared.
  6. Alice Emptoz

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  7. Alexandre Parrin

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  8. Sylvie Nouaille

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  9. Marc Guillon

    Centre National de la Recherche Scientifique UMR 8250, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
    Competing interests
    No competing interests declared.
  10. Martin Sachse

    Center for Innovation and Technological Research, Ultrapole, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  11. Danica Ciric

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  12. Amel Bahloul

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  13. Jean-Pierre Hardelin

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  14. Roger Bryan Sutton

    Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, United States
    Competing interests
    No competing interests declared.
  15. Paul Avan

    Laboratoire de Biophysique Sensorielle, Université d'Auvergne, Clermont-Ferrand, France
    Competing interests
    No competing interests declared.
  16. Shyam S Krishnakumar

    Department of Cell Biology, Yale University School of Medicine, New Haven, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6148-3251
  17. James E Rothman

    Department of Cell Biology, Yale University School of Medicine, New Haven, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8653-8650
  18. Didier Dulon

    UMRS 1120, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
    Competing interests
    No competing interests declared.
  19. Saaid Safieddine

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
  20. Christine Petit

    Unité de Génétique et Physiologie de l'Audition, Institut Pasteur, Paris, France
    For correspondence
    christine.petit@pasteur.fr
    Competing interests
    Christine Petit, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9069-002X

Funding

Foundation Raymonde et Guy Strittmatter (Research project grant)

  • Christine Petit

Foundation BNP Parisbas (Research project grant)

  • Christine Petit

LHW-Stiftung (Research project grant)

  • Christine Petit

LabExLifesenses (ANR‐10‐LABX‐65)

  • Christine Petit

Investissements d'Avenir (ANR‐11‐IDEX‐0004‐02)

  • Christine Petit

Agir pour l'Audition (Prix Emergence scientifique)

  • Nicolas Antoine Michalski

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experiments were carried out in accordance with European Community Council Directive 2010/63/UE under authorizations 2012-028, 2012-038, and 2014-005 from the Institut Pasteur ethics committee for animal experimentation.

Copyright

© 2017, Michalski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,247
    views
  • 612
    downloads
  • 95
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicolas Antoine Michalski
  2. Juan D Goutman
  3. Sarah Marie Auclair
  4. Jacques Boutet de Monvel
  5. Margot Tertrais
  6. Alice Emptoz
  7. Alexandre Parrin
  8. Sylvie Nouaille
  9. Marc Guillon
  10. Martin Sachse
  11. Danica Ciric
  12. Amel Bahloul
  13. Jean-Pierre Hardelin
  14. Roger Bryan Sutton
  15. Paul Avan
  16. Shyam S Krishnakumar
  17. James E Rothman
  18. Didier Dulon
  19. Saaid Safieddine
  20. Christine Petit
(2017)
Otoferlin acts as a Ca2+ sensor for vesicle fusion and vesicle pool replenishment at auditory hair cell ribbon synapses
eLife 6:e31013.
https://doi.org/10.7554/eLife.31013

Share this article

https://doi.org/10.7554/eLife.31013

Further reading

    1. Neuroscience
    Ana Maria Ichim, Harald Barzan ... Raul Cristian Muresan
    Review Article

    Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.

    1. Neuroscience
    John P Grogan, Matthias Raemaekers ... Sanjay G Manohar
    Research Article

    Motivation depends on dopamine, but might be modulated by acetylcholine which influences dopamine release in the striatum, and amplifies motivation in animal studies. A corresponding effect in humans would be important clinically, since anticholinergic drugs are frequently used in Parkinson’s disease, a condition that can also disrupt motivation. Reward and dopamine make us more ready to respond, as indexed by reaction times (RT), and move faster, sometimes termed vigour. These effects may be controlled by preparatory processes that can be tracked using electroencephalography (EEG). We measured vigour in a placebo-controlled, double-blinded study of trihexyphenidyl (THP), a muscarinic antagonist, with an incentivised eye movement task and EEG. Participants responded faster and with greater vigour when incentives were high, but THP blunted these motivational effects, suggesting that muscarinic receptors facilitate invigoration by reward. Preparatory EEG build-up (contingent negative variation [CNV]) was strengthened by high incentives and by muscarinic blockade, although THP reduced the incentive effect. The amplitude of preparatory activity predicted both vigour and RT, although over distinct scalp regions; frontal activity predicted vigour, whereas a larger, earlier, central component predicted RT. The incentivisation of RT was partly mediated by the CNV, though vigour was not. Moreover, the CNV mediated the drug’s effect on dampening incentives, suggesting that muscarinic receptors underlie the motivational influence on this preparatory activity. Taken together, these findings show that a muscarinic blocker impairs motivated action in healthy people, and that medial frontal preparatory neural activity mediates this for RT.